Concepedia

Meixia Chen

MC

Statistics

Publications

64

Citations

5.2K

H-Index

31

Active since

2009

Affiliations

Chinese PLA General Hospital(Current)

China Agricultural University

Beijing Academy of Agricultural and Forestry Sciences

Chinese Academy of Sciences

Ningde Normal University

Meixia Chen is an author at Chinese PLA General Hospital specializing in cancer immunotherapy, life sciences, and oncology.

Publications per year

2009–2024

64

Publications

64

Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy

Mengze Lv, Meixia Chen, Rui Zhang et al. · Cell Research · 2020 · 1K citations · Full text

, , +17

Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

Chunmeng Wang, Zhiqiang Wu, Yao Wang et al. · Clinical Cancer Research · 2016 · 328 citations

, , +17

CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial

Yao Wang, Meixia Chen, Zhiqiang Wu et al. · OncoImmunology · 2018 · 328 citations · Full text

, , +17

Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

Hanren Dai, Zhiqiang Wu, Hejin Jia et al. · Journal of Hematology & Oncology · 2020 · 323 citations · Full text

, , +11

Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors

Zhenguang Wang, Na Li, Kaichao Feng et al. · Cellular and Molecular Immunology · 2021 · 257 citations · Full text

, , +17

1–5 of 64